CAS 2180923-05-9

Fórmula: C45H48ClN7O8S

InChI: InChI=1S/C45H48ClN7O8S/c46-33-4-2-30(3-5-33)39-25-45(12-1-13-45)14-10-32(39)28-51-16-18-52(19-17-51)34-6-8-38(42(23-34)61-35-22-31-11-15-47-43(31)49-26-35)44(54)50-62(57,58)37-7-9-40(41(24-37)53(55)56)48-27-36-29-59-20-21-60-36/h2-9,11,15,22-24,26,36,48H,1,10,12-14,16-21,25,27-29H2,(H,47,49)(H,50,54)/t36-/m0/s1

Clave InChI: FNBXDBIYRAPDPI-BHVANESWSA-N

SMILES: C1CC2(C1)CCC(=C(C2)C3=CC=C(C=C3)Cl)CN4CCN(CC4)C5=CC(=C(C=C5)C(=O)NS(=O)(=O)C6=CC(=C(C=C6)NC[C@H]7COCCO7)[N+](=O)[O-])OC8=CN=C9C(=C8)C=CN9

(S)-N-((4-(((1,4-Dioxan-2-yl)methyl)amino)-3-nitrophenyl)sulfonyl)-2-((1H-pyrrolo[2,3-b]pyridin-5-yl)oxy)-4-(4-((6-(4-chlorophenyl)spiro[3.5]non-6-en-7-yl)methyl)piperazin-1-yl)benzamide

CAS: 2180923-05-9

Pureza: 98%

Ref: IN-DA01V4UT

Lisaftoclax

CAS: 2180923-05-9

Lisaftoclax

Fórmula: C₄₅H₄₈ClN₇O₈S

Pureza: ≥95%

Peso molecular: 882.42

Ref: 54-BUP06963

Lisaftoclax

CAS: 2180923-05-9

Lisaftoclax, an oral Bcl-2/Bcl-xl inhibitor (IC50: 2 nM & 5.9 nM), treats CLL by promoting leukemia cell death.

Fórmula: C₄₅H₄₈ClN₇O₈S

Pureza: 97.14% - 99.66%

Forma y color: Yellow Solid

Peso molecular: 882.42

Ref: TM-T10483